MedPath

University of Milano-Bicocca

University of Milano-Bicocca logo
🇮🇹Italy
Ownership
Private
Established
1998-01-01
Employees
-
Market Cap
-
Website
http://www.unimib.it

Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma

Phase 2
Not yet recruiting
Conditions
Glioblastoma, IDH-wildtype
Metformin
Malignancies
Interventions
First Posted Date
2023-07-03
Last Posted Date
2023-11-09
Lead Sponsor
University of Milano Bicocca
Target Recruit Count
25
Registration Number
NCT05929495
Locations
🇮🇹

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy

"Don't Eat me" Signal in Hematological Malignancies: CD24 as New Target to Improve Anti-cancer Immunity.

Recruiting
Conditions
B Cell Chronic Lymphocytic Leukemia
Mantle-cell Lymphoma
First Posted Date
2023-06-05
Last Posted Date
2023-06-05
Lead Sponsor
University of Milano Bicocca
Target Recruit Count
30
Registration Number
NCT05888701
Locations
🇮🇹

Andrea Aroldi, Monza, MB, Italy

In Vitro Modeling of Drug-resistant Psychiatric Disorders Using Induced Pluripotent Cells

Conditions
Depressive Disorder, Treatment-Resistant
First Posted Date
2023-06-02
Last Posted Date
2023-06-02
Lead Sponsor
University of Milano Bicocca
Target Recruit Count
50
Registration Number
NCT05887310
Locations
🇮🇹

Fondazione IRCCS San Gerardo di Monza, Monza, Monza E Brianza, Italy

Vancomycin in Primary Sclerosing Cholangitis in Italy

Phase 2
Recruiting
Conditions
Liver and Intrahepatic Bile Duct Disorder
Primary Sclerosing Cholangitis
IBD
Interventions
Other: Placebo
First Posted Date
2023-05-25
Last Posted Date
2023-07-03
Lead Sponsor
University of Milano Bicocca
Target Recruit Count
84
Registration Number
NCT05876182
Locations
🇮🇹

Fondazione IRCCS San Gerardo dei Tintori, Monza, Monza E Brianza, Italy

Dual Anti-glutamate Therapy in Super-refractory Status Epilepticus After Cardiac Arrest

Recruiting
Conditions
Status Epilepticus
Cardiac Arrest
Interventions
Drug: Any anti-epileptic and anesthetic therapy, excluding Ketamine and Perampanel
First Posted Date
2023-03-06
Last Posted Date
2024-12-19
Lead Sponsor
University of Milano Bicocca
Target Recruit Count
80
Registration Number
NCT05756621
Locations
🇮🇹

ASST Spedali Civili Brescia, Brescia, BS, Italy

🇮🇹

Ospedale Centrale di Bolzano, Bolzano, BZ, Italy

🇮🇹

Ospedale G. Brotzu, Cagliari, CA, Italy

and more 7 locations

Clinical Applicability of pCASL as a Substitute for FDG-PET in MCI and SCD Patients

Recruiting
Conditions
Mild Cognitive Impairment
Subjective Cognitive Decline
First Posted Date
2023-03-06
Last Posted Date
2023-08-01
Lead Sponsor
University of Milano Bicocca
Target Recruit Count
150
Registration Number
NCT05756270
Locations
🇮🇹

Fondazione IRCCS San Gerardo dei Tintori, Monza, MB, Italy

Monitoring Antiplatelet Drugs in Cardiac Arrest Patients

Recruiting
Conditions
Myocardial Infarction
Cardiac Arrest
Extracorporeal Membrane Oxygenation
Platelet Dysfunction
Interventions
Drug: Antiplatelet Drug
First Posted Date
2023-02-15
Last Posted Date
2023-02-15
Lead Sponsor
University of Milano Bicocca
Target Recruit Count
60
Registration Number
NCT05730114
Locations
🇮🇹

IRCCS San Gerardo dei Tintori, Monza, MB, Italy

Candidate Gene for Hyperferritinemia

Recruiting
Conditions
Hyperferritinemia
First Posted Date
2022-12-21
Last Posted Date
2024-01-05
Lead Sponsor
University of Milano Bicocca
Target Recruit Count
100
Registration Number
NCT05659017
Locations
🇮🇹

Centre for Rare Disease - Disorders of Iron Metabolism, ASST-Monza, San Gerardo Hospital, European Reference Network - EuroBloodNet, Monza, MB, Italy

Efficacy of a Tailored Communication Intervention Aimed At Increasing the Number of Daily Steps

Not Applicable
Recruiting
Conditions
Physical Inactivity
First Posted Date
2022-11-17
Last Posted Date
2024-12-09
Lead Sponsor
University of Milano Bicocca
Target Recruit Count
255
Registration Number
NCT05620888
Locations
🇮🇹

University of Milano-Bicocca, Milan, MI, Italy

National Database on Primary Sclerosing Cholangitis (PSC)

Recruiting
Conditions
Primary Sclerosing Cholangitis
Interventions
Other: Clinical information
First Posted Date
2022-11-16
Last Posted Date
2024-01-02
Lead Sponsor
University of Milano Bicocca
Target Recruit Count
6000
Registration Number
NCT05618145
Locations
🇮🇹

Ospedali riuniti di Ancona, Ancona, Italy

🇮🇹

Policlinico di Bari, Bari, Italy

🇮🇹

ASST Bergamo ovest, Bergamo, Italy

and more 60 locations
© Copyright 2025. All Rights Reserved by MedPath